Immunology researchers have found an important safety mechanism in the immune system that may malfunction in people with autoimmune diseases, such as Multiple Sclerosis, potentially paving the way for innovative treatments. Published in Immunity, 6 Sept 2013, the research, led by Head of the Monash Department of Immunology Professor Fabienne Mackay, describes for the first time how the body manages marginal zone (MZ) B cells, which form a general first line of attack against germs, but are potentially harmful.
- Monash story
- Journal reference
- Animation prepared by first author Dr Will Figgett;
- Video of Fabienne Mackay explaining the significance of the research;
- BAFF lab link.
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.